US Begins Study On Allergic Reaction Risk In Moderna, Pfizer Vaccines US Begins Study On Allergic Reaction Risk In Moderna, Pfizer Vaccines Several allergic reaction incidents, including serious episodes, known as anaphylaxis, have been reported in the US after vaccinations of Pfizer/BioNTech and Moderna shots.
US Begins Study On Allergic Reaction Risk In Moderna, Pfizer Vaccines
The US National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc.
Several allergic reaction incidents, including serious episodes, known as anaphylaxis, have been reported in the US after vaccinations of Pfizer/BioNTech and Moderna shots.
Holocaust survivors at a nursing home in Tel Aviv, May 4, 2016.
The damaging effects of life under Nazi rule have long been known with many victims having experienced periods of protracted emotional and physical torture, malnutrition, and mass exposure to disease. But recent research from the Hebrew University of Jerusalem shows that even for those who survived, their health and mortality continued to be directly impacted long after the end of the Holocaust.
The study, led by Dr. Iaroslav Youssim and Dr. Hagit Hochner from the School of Public Health at the Faculty of Medicine and published in the American Journal of Epidemiology (
Washington [US], April 8 (ANI): US National Institutes of Health (NIH) announced on Wednesday that it is launching a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals. A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate and systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines. The public understandably has been concerned about reports of rare, severe allergic reactions to the Moderna and Pfizer-BioNTech COVID-19 vaccines, said Anthony S Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The information gathered during this trial will help doctors advise people who are highly allergic or have a mast cell disorder about the risks and benefits of receiving these two vaccines. However, for most people, t
COVID-19: US begins study assessing allergic reactions to Pfizer, Moderna vaccines ANI | Updated: Apr 08, 2021 08:27 IST
By Reena Bhardwaj
Washington [US], April 8 (ANI): US National Institutes of Health (NIH) announced on Wednesday that it is launching a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Modernavaccines among certain individuals.
A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate and systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19vaccines. The public understandably has been concerned about reports of rare, severe allergic reactions to the Moderna and Pfizer-BioNTech COVID-19vaccines, said Anthony S Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The information gathered during this trial will